Chad Sheaffer, CFA, CAIA
Senior Research Analyst
While investors scrutinize rhetoric from the Trump administration for its potential to ignite another bout of inflation for U.S. consumers, one challenge is already ruffling feathers at the grocery store. Egg prices have surged amid a resurgence in avian flu cases as farmers have been forced to cull millions of egg-laying hens to protect healthy flocks. According to the Bureau of Labor Statistics, the average cost for Grade A large eggs reached $4.15 per dozen in December, which represents a more than 13% increase from November and a 65% year-over-year rise. In some states, costs have far exceeded the national average, with wholesale prices surpassing $7.24 and $8.35 per dozen in New York and California, respectively.
The latest outbreak has proven particularly severe, with more than 14.7 million egg-producing chickens infected in January alone (more than the total for all of 2023 following the initial outbreak of the flu). With the virus present in all 50 states, the CDC estimates that at least 150 million birds, including both commercial poultry and wild birds, have been affected since 2022. With no definitive end to the flu outbreak in sight, egg producers are lobbying the federal government to fund vaccine research as a potential long-term solution. As Easter approaches, rising demand for eggs could further exacerbate issues and potentially drive prices to record highs. The U.S. Department of Agriculture forecasts an additional 20% increase in egg prices through the end of this year due to shortages, with some grocery stores already struggling to maintain supplies and others instituting limits on purchases.
While the current price of eggs has been driven higher by the flu outbreak, trade restrictions could have a far greater impact on inflation for U.S. consumers. Consequently, investors must weigh the domestic supply shocks for eggs and other goods alongside ongoing trade uncertainties and accept that inflation and elevated interest rates may persist through 2025.
Print PDFThe opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
07.17.2025
As we enter the second half of the year, Liberation Day-induced market volatility seems like a distant memory with the…
07.15.2025
Fiduciaries, trustees, and institutional investors may be understandably puzzled by recent developments and shifts in tone from U.S. regulators and…
07.09.2025
The One Big Beautiful Bill Act was passed by Congress and signed into law by President Donald Trump on July…
07.07.2025
Late last week, President Trump signed a sweeping tax and spending package, branded by the White House as the “One…
07.03.2025
Please join Marquette’s research team for our 2025 Halftime Market Insights Webinar analyzing the first half of the…
06.30.2025
NATO has decided to take the phrase “don’t bring a knife to a gun fight” quite literally. Last week at…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >